Navigation Links
Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance
Date:12/11/2008

imal health division. However, due to the negative impact of weaker foreign currencies and the impact of generic competition in certain markets for Gemzar(R), reported sales are expected to grow in the low-single digits.

The company expects gross margin as a percent of sales to increase substantially, driven by the strengthening dollar. This impact could be particularly pronounced in the first and second quarters of 2009.

Marketing, selling, and administrative expenses are projected to show flat to low-single digit growth while research and development expenses are projected to grow in the low-single digits. Operating expenses, as defined as the sum of marketing, selling and administrative expenses and research and development expenses, are expected to grow more slowly than sales, registering flat to low-single digit growth.

Other income is expected to contribute less than $75 million, and the tax rate is expected to be approximately 22 percent. Capital expenditures are expected to remain level at approximately $1.1 billion and the company expects continued strong operating cash flow.

In addition, the company reaffirmed its commitment to generate double-digit compound annual earnings per share growth between 2007 and 2011.

Webcast of Investment Community Meeting

A live webcast of the Lilly Investment Community meeting, along with presentation slides, is available through a link on Lilly's web site at www.lilly.com. The meeting will start today at 8:30 a.m. Eastern Time and last until approximately 12:30 p.m. The webcast will be available for replay through January 9, 2009.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborat
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Prinz Law Office has announced the launch of several ... secure legal services in the current economic climate. ... the opportunity to finance legal services over a period ... any equity in their start-up companies. The second ... fixed montly payment arrangements over 6 to 12 month ...
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
(Date:12/14/2009)... ThermoFab, a US-based thermoforming company, has completed the delivery of ... sheet metal to a plastic enclosure with a smaller footprint ... ... Shirley, MA (PRWEB) December 14, 2009 -- ThermoFab, a US-based ... Flow Tester – helping Brookfield move from sheet metal to ...
(Date:12/11/2009)... 2009 -- Researchers have discovered a new explanation for differences ... excess copies of a certain gene, the more serious the ... it is suspected that it is the amount of copies ... being published in the American Journal of Human Genetics ... of Guy Froyen connected to VIB, a life sciences research ...
Breaking Biology Technology:The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Amount of gene surplus determines severity of mental retardation in males 2
... Phase 3 Registration Trial No Later Than ... ... a biopharmaceutical company developing patient-specific, active,immunotherapies for the treatment of cancer, today ... the quarter and year,ended December 31, 2007, the Company reported net losses ...
... Developing a credit-card-sized gas chromatography platform that ... next step for Virginia Tech College of Engineering ... Science Foundation (NSF) Faculty Early Career Development Program ... an assistant professor in the Bradley Department of ...
... First Choice Professionals, LLC.,today announced the addition of ... Mark will join FCP as Program,Management Office and ... of Healthcare IT thought leadership,experience to FCP. Prior ... of systems support at Catholic Healthcare West. Prior ...
Other Biology Technology:Favrille Reports Fourth Quarter and Year End 2007 Financial Results 2Favrille Reports Fourth Quarter and Year End 2007 Financial Results 3Favrille Reports Fourth Quarter and Year End 2007 Financial Results 4Favrille Reports Fourth Quarter and Year End 2007 Financial Results 5Favrille Reports Fourth Quarter and Year End 2007 Financial Results 6Favrille Reports Fourth Quarter and Year End 2007 Financial Results 7Favrille Reports Fourth Quarter and Year End 2007 Financial Results 8Favrille Reports Fourth Quarter and Year End 2007 Financial Results 9Credit-card-sized platform for volatile compound analysis CAREER project goal 2FCP Welcomes Mark Scherling 2
(Date:12/15/2009)... - Scientists at VIB and Ghent University in Flanders, ... of septic shock, the major cause of death in ... oxide (NO) gas in mice with septic shock, researchers ... organs showed much less damage, while their chances of ... it is generally assumed that nitric oxide is responsible ...
(Date:12/15/2009)... This release is available in German ... laws everywhere across the globe, cultures vary as to ... example, do not use egocentric terms such as ,left, ... using allocentric notions like ,north, south, east, west, at ... of the bowl" or "There is an snake by ...
(Date:12/15/2009)... This release is available in German ... use in predicting the future distribution of mammals. This ... niches of 140 indigenous European mammals. The researchers analysed ... as well as the phylogenetic information of the species. ... for closely related species, mammals seem to adapt fast ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2More than a jump to the left 2Species distribution models are of only limited value for predicting future mammal distributions 2Private and public insurance choices could help pay for national health care reform 51976 1Private and public insurance choices could help pay for national health care reform 51976 2Private and public insurance choices could help pay for national health care reform 51976 3Baylor Dallas Recognized In U S News Media Groups 2009 2010 Americas Best Hospitals 51971 1Baylor Dallas Recognized In U S News Media Groups 2009 2010 Americas Best Hospitals 51971 2Baylor Dallas Recognized In U S News Media Groups 2009 2010 Americas Best Hospitals 51971 3Justice Department Releases New Fact Sheet on the Rights of Persons With HIV or AIDS to Obtain Occupational Training and State Licensing 51967 1
... a study to be published in the January 2006 ... of scientists at Memorial Sloan-Kettering Cancer Center have devised ... and RNA interference to genetically reverse sickle cell disease ... to demonstrate a way to genetically correct this debilitating ...
... helping to spread spores of pathogen , Biologists studying ... Columbia present strong evidence in the September issue of ... outbreak. The blight, caused by the fungus Dothistroma septosporum, ... case of the British Columbia outbreak, eventually die. D. ...
... between advantage and disadvantage , Some viruses' ability to ... replication may be both a blessing and curse, according ... at the Johns Hopkins Bloomberg School of Public Health. ... antibody-dependent enhancement may allow the dengue virus to grow ...
Other Biology News:Sickle cell disease corrected in human models using stem cell-based gene therapy 2Computer models aid understanding of antibody-dependent enhancement in spread of dengue fever 2
... Genomic Labeling Systems are a high-performance labeling ... DNA samples for array-based Comparative Genomic Hybridization ... labeling formats, the BioPrime Plus Array CGH ... to your genomic labeling needs. Using ...
... interferons are cytopathic effect inhibition assays, also known ... include; tissue culture supernatents; serum from PK studies ... unit is defined as the quantity of interferon ... of viral infection by 50%. All ...
Request Info...
...
Biology Products: